Table 2.
Adverse Events
| HSCT 2–5 yr (n = 26) |
HSCT > 5 yr (n = 15) |
Chemotherapy (n = 15) | Healthy (n = 30) |
|
|---|---|---|---|---|
| Any adverse events, n (%) | 5 (19.2) | 3 (20.0) | 2 (13.3) | 0 (0) |
| Local adverse events, n (%) | 4 (15.4) | 2 (13.3) | 1 (6.6) | 0 (0) |
| Pain or tenderness | 3 (11.5) | 2 (13.3) | 1 (6.6) | 0 (0) |
| Redness | 3 (11.5) | 2 (13.3) | 1 (6.6) | 0 (0) |
| Induration or edema | 1 (3.8) | 2 (13.3) | 1 (6.6) | 0 (0) |
| Itching | 3 (11.5) | 2 (13.3) | 1 (6.6) | 0 (0) |
| Systemic adverse events, n (%) | 3 (11.5) | 1 (6.6) | 1 (6.6) | 0 (0) |
| Headache | 1 (3.8) | 1 (6.6) | 0 (0) | 0 (0) |
| Myalgia or arthralgia | 3 (11.5) | 1 (6.6) | 0 (0) | 0 (0) |
| Fatigue | 3 (11.5) | 0 (0) | 1 (6.6) | 0 (0) |
| Fever | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Systemic allergic reaction | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Nausea or vomiting | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Diarrhea | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
HSCT Hematopoietic stem cell transplantation, N Number